Drugs / Zemestosita
last change Mar 2026 re-read 2 minutes ago

Zemestosita

Developed for
acute myeloid leukemia
Investigated by
Liping Dou

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07651475 Mar 2026 overdue acute myeloid leukemia Liping Dou Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Zemestosita ClinicalTrials.gov intervention name — accepted as the source's own label NCT07651475